Does metabolically healthy obesity really exist: going toward new definitions
The Journal of Clinical Endocrinology & Metabolism · 16.09.2026 · 111 (10) · e2227-e2259
DOI: 10.1210/clinem/dgag247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 24.06.2026. Verfasst von Christian Rodriguez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA. Hauptthemen laut MEDLINE: Obesity, Metabolically Benign. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Context
Obesity is a heterogeneous chronic disease traditionally defined by body mass index, yet individuals with similar body mass index values can exhibit substantial variability in the presence of cardiometabolic risk factors independent of adiposity. Such discordance has led to the concept of “metabolically healthy obesity,” describing individuals with excess adiposity but without overt metabolic abnormalities. However, the validity and clinical relevance of metabolically healthy obesity remain controversial. Evidence Acquisition We conducted a narrative review of PubMed-indexed studies examining obesity phenotypes considering the recent preclinical/clinical obesity framework proposed by the Lancet Commission on Diabetes and Endocrinology. Preference was given for large epidemiological cohorts and mechanistic studies with detailed phenotyping. Evidence Synthesis The metabolically healthy obesity concept is limited by inconsistent definitions, reliance on cardiometabolic risk factors, and poor long-term stability. Emerging evidence supports a shift toward a disease-based framework distinguishing preclinical obesity (excess adiposity with preserved organ and tissue function) from clinical obesity which is associated with organ dysfunction.
Conclusion
Replacing binary metabolic phenotypes with the preclinical and clinical obesity framework proposed by the Lancet Commission provides a biologically grounded, clinically actionable model that aligns obesity classification with organ dysfunction and disease progression. Adopting a continuum-based, function-oriented approach may improve risk stratification, guide therapeutic prioritization, and reduce misconceptions surrounding “benign” obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
ORCID-Profile: Christian Rodriguez, Eric Ravussin
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Rodriguez, C., & Ravussin, E. (2026). Does metabolically healthy obesity really exist: going toward new definitions. The Journal of Clinical Endocrinology & Metabolism, 111(10), e2227-e2259. https://doi.org/10.1210/clinem/dgag247
Vancouver
Rodriguez C, Ravussin E. Does metabolically healthy obesity really exist: going toward new definitions. The Journal of Clinical Endocrinology & Metabolism. 2026;111(10):e2227-e2259. doi:10.1210/clinem/dgag247
BibTeX
@article{Rodriguez2026,
author = {Rodriguez, Christian and Ravussin, Eric},
title = {Does metabolically healthy obesity really exist: going toward new definitions},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {10},
pages = {e2227--e2259},
doi = {10.1210/clinem/dgag247}
}
EUVIMED